There are a diversity of interpretations concerning the possible roles of phospholipase D and its biologically active product phosphatidic acid in the late, Ca2+-triggered steps of regulated exocytosis. To quantitatively address functional and molecular aspects of the involvement of phospholipase D-derived phosphatidic acid in regulated exocytosis, we used an array of phospholipase D inhibitors for ex vivo and in vitro treatments of sea urchin eggs and isolated cortices and cortical vesicles, respectively, to study late steps of exocytosis, including docking/priming and fusion. The experiments with fluorescent phosphatidylcholine reveal a low level of phospholipase D activity associated with cortical vesicles but a significantly higher activity on the plasma membrane. The effects of phospholipase D activity and its product phosphatidic acid on the Ca2+ sensitivity and rate of fusion correlate with modulatory upstream roles in docking and priming rather than to direct effects on fusion per se.
Human pigmentation is determined by melanosome development and melanin production through melanogenesis, a process regulated by melanogenic proteins. A single nucleotide polymorphism (A111T) in the SLC24A5 gene, which encodes the K⁺-dependent Na⁺/Ca2⁺ exchanger NCKX5, is a major determinant of normal variation in human skin and iris colour. Despite the suggested role of NCKX5 in skin pigmentation, its ion transport function in melanogenesis remains unclear. To address this, we silenced SLC24A5 in pigmented human MNT1 melanoma cells using CRISPR/Cas9-mediated knockout. Loss of NCKX5 resulted in a marked reduction in eumelanin levels and the formation of abnormal, non-uniform melanosomes with defective fibrillar structure. To evaluate the functional role of NCKX5, we reconstituted depigmented cells with myc-tagged NCKX5 variants, including the transport-deficient mutant D383N. Reconstitution with the A111 variant of NCKX5 restored eumelanin synthesis more effectively than the T111 variant, whereas the D383N variant failed to rescue pigmentation. Moreover, the addition of the lysosomotropic weak base NH4Cl to the growth medium, which neutralizes the acidic pH of intracellular organelles, markedly increased eumelanin content in depigmented cells lacking NCKX5, suggesting a link between NCKX5-mediated Ca2+ transport activity in the TGN and melanosomal pH regulation. We also discuss the many NCKX5 mutants that have been reported to affect pigmentation in both humans (Oculocutaneous albinism or OCA6) and animals in the context of their potential effects on NCKX5-mediated Ca2+ transport activity.
Human pigmentation is determined by melanosome development and melanin production through melanogenesis, a process regulated by melanogenic proteins. A single nucleotide polymorphism (A111T) in the SLC24A5 gene, which encodes the K+-dependent Na+/Ca2+ exchanger NCKX5, is a major determinant of normal variation in human skin and iris colour. Despite the suggested role of NCKX5 in skin pigmentation, its ion transport function in melanogenesis remains unclear. To address this, we silenced SLC24A5 in pigmented human MNT1 melanoma cells using CRISPR/Cas9-mediated knockout. Loss of NCKX5 resulted in a marked reduction in eumelanin levels and the formation of abnormal, non-uniform melanosomes with defective fibrillar structure. To evaluate the functional role of NCKX5, we reconstituted depigmented cells with myc-tagged NCKX5 variants, including the transport-deficient mutant D383N. Reconstitution with the A111 variant of NCKX5 restored eumelanin synthesis more effectively than the T111 variant, whereas the D383N variant failed to rescue pigmentation. Moreover, the addition of the lysosomotropic weak base NH4Cl, to the growth medium, which neutralizes the acidic pH of intracellular organelles, markedly increased eumelanin content in depigmented cells lacking NCKX5, suggesting a link between NCKX5-mediated Ca2+ transport activity in the TGN and melanosomal pH regulation. We also discuss the many NCKX5 mutants that have been reported to affect pigmentation in both humans (Oculocutaneous albinism or OCA6) and animals in the context of their potential effects on NCKX5-mediated Ca2+ transport activity.